Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »


Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »


The Share

Latest News

Anders Blom new Executive Vice President in Oasmia

September 1 2014
The pharmaceutical company Oasmia Pharmaceutical announced today that Anders Blom has been appointed Executive Vice President in Oasmia. He is succeeding Hans Sundin who is nominated to become a new member of the Board of Directors of Oasmia.
Further reading »

Notice convening the Annual General Meeting of Oasmia Pharmaceutical AB

September 1 2014
The shareholders of Oasmia Pharmaceutical AB (publ), 556332-6676, are invited to participate in the Annual General Meeting to be held on Monday, September 29, 2014 at 2 p.m. at Vallongatan 1, Uppsala, Sweden. The registration will start at 1.30 p.m.
Further reading »

The Oasmia Pharmaceutiacal Annual Report is now published

August 21 2014
Further reading »

bottom